The use of PCSK9 inhibitors should be avoided during pregnancy: results from a Mendelian randomization study.

Efird, Jimmy T

Efird, Jimmy T.

Affiliation

Efird JT; VA Cooperative Studies Program Coordinating Center, Lafayette City Center, 2 Avenue de Lafayette, Boston, MA 02111, USA.

Eur J Prev Cardiol ; 31(8): 954, 2024 Jun 03.

Article in En | MEDLINE | ID: mdl-38225181

Subject(s)

Mendelian Randomization Analysis; PCSK9 Inhibitors; Humans; Female; Pregnancy; Anticholesteremic Agents/therapeutic use; Risk Assessment; Biomarkers/blood; Cholesterol, LDL/blood; Risk Factors; Proprotein Convertase 9

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mendelian Randomization Analysis / PCSK9 Inhibitors Type of study: Clinical_trials Limits: Female / Humans / Pregnancy Language: En Journal: Eur J Prev Cardiol Year: 2024 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google